HIV Drugs

Global Market Trajectory & Analytics

MCP-6176

EXECUTIVE ENGAGEMENTS

OUTREACH

8299
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1162
Interactions with Platform & by Email

PARTICIPANTS

249
Unique # Participated

VALIDATIONS

112
Responses Validated*

COMPETITORS

52
Responses Validated*

BRANDS

0
Responses Validated*
* Login for a full stack data experience

DATE

JUL 2020

TABLES

123

PAGES

205

EDITION

16

PRICE

USD $5450


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for HIV Drugs estimated at US$22.8 Billion in the year 2020, is projected to reach a revised size of US$26.8 Billion by 2027, growing at a CAGR of 2.3% over the analysis period 2020-2027. Multi-Class Combination Drugs, one of the segments analyzed in the report, is projected to record a 2.7% CAGR and reach US$9.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nucleoside Reverse Transcriptase Inhibitors (NRTIs) segment is readjusted to a revised 2.7% CAGR for the next 7-year period.
The HIV Drugs market in the U.S. is estimated at US$6.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.5% and 1.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1% CAGR.
In the global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) segment, USA, Canada, Japan, China and Europe will drive the 1.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.7 Billion in the year 2020 will reach a projected size of US$2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.6 Billion by the year 2027, while Latin America will expand at a 2.9% CAGR through the analysis period.

SELECT PLAYERS

AbbVie, Inc.; AstraZeneca PLC; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Cipla Ltd.; Daiichi Sankyo Co., Ltd.; Emcure Pharmaceuticals Pvt., Ltd.; F. Hoffmann-La Roche AG; Gilead Sciences, Inc.; Hetero Drugs Ltd.; Johnson & Johnson; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd.; ViiV Healthcare

SEGMENTS

» Medication Class [Multi-Class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Fusion Inhibitors (FI), Entry Inhibitors, and HIV Integrase Stand Transfer Inhibitors]

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Global Competitor Market Shares
HIV Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
HIV Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
HIV Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
HIV Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Multi-Class Combination Drugs (Medication Class) World Market by Region/Country in US$ Million: 2018 to 2025
Multi-Class Combination Drugs (Medication Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Multi-Class Combination Drugs (Medication Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (Medication Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (Medication Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (Medication Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Medication Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Medication Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Medication Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Protease Inhibitors (PIs) (Medication Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
Protease Inhibitors (PIs) (Medication Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
Protease Inhibitors (PIs) (Medication Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
Fusion Inhibitors (FI) (Medication Class) World Market by Region/Country in US$ Million: 2018 to 2025
Fusion Inhibitors (FI) (Medication Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Fusion Inhibitors (FI) (Medication Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Entry Inhibitors (Medication Class) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
Entry Inhibitors (Medication Class) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
Entry Inhibitors (Medication Class) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
HIV Integrase Stand Transfer Inhibitors (Medication Class) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
HIV Integrase Stand Transfer Inhibitors (Medication Class) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
HIV Integrase Stand Transfer Inhibitors (Medication Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US HIV Drugs Market Share (in %) by Company: 2019 & 2025
United States HIV Drugs Market Estimates and Projections in US$ Million by Medication Class: 2018 to 2025
HIV Drugs Market in the United States by Medication Class: A Historic Review in US$ Million for 2009-2017
United States HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Canada
Canadian HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018 to 2025
Canadian HIV Drugs Historic Market Review by Medication Class in US$ Million: 2009-2017
HIV Drugs Market in Canada: Percentage Share Breakdown of Sales by Medication Class for 2009, 2019, and 2025
Japan
Japanese Market for HIV Drugs: Annual Sales Estimates and Projections in US$ Million by Medication Class for the Period 2018-2025
HIV Drugs Market in Japan: Historic Sales Analysis in US$ Million by Medication Class for the Period 2009-2017
Japanese HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025
China
Chinese HIV Drugs Market Growth Prospects in US$ Million by Medication Class for the Period 2018-2025
HIV Drugs Historic Market Analysis in China in US$ Million by Medication Class: 2009-2017
Chinese HIV Drugs Market by Medication Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Europe
Market Facts & Figures
European HIV Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European HIV Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
HIV Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European HIV Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018-2025
HIV Drugs Market in Europe in US$ Million by Medication Class: A Historic Review for the Period 2009-2017
European HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
France
HIV Drugs Market in France by Medication Class: Estimates and Projections in US$ Million for the Period 2018-2025
French HIV Drugs Historic Market Scenario in US$ Million by Medication Class: 2009-2017
French HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025
Germany
HIV Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025
German HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017
German HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Italy
Italian HIV Drugs Market Growth Prospects in US$ Million by Medication Class for the Period 2018-2025
HIV Drugs Historic Market Analysis in Italy in US$ Million by Medication Class: 2009-2017
Italian HIV Drugs Market by Medication Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Kingdom
United Kingdom Market for HIV Drugs: Annual Sales Estimates and Projections in US$ Million by Medication Class for the Period 2018-2025
HIV Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Medication Class for the Period 2009-2017
United Kingdom HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025
Spain
Spanish HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018 to 2025
Spanish HIV Drugs Historic Market Review by Medication Class in US$ Million: 2009-2017
HIV Drugs Market in Spain: Percentage Share Breakdown of Sales by Medication Class for 2009, 2019, and 2025
Russia
Russian HIV Drugs Market Estimates and Projections in US$ Million by Medication Class: 2018 to 2025
HIV Drugs Market in Russia by Medication Class: A Historic Review in US$ Million for 2009-2017
Russian HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Rest of Europe
Rest of Europe HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018-2025
HIV Drugs Market in Rest of Europe in US$ Million by Medication Class: A Historic Review for the Period 2009-2017
Rest of Europe HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Asia-Pacific
Asia-Pacific HIV Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
HIV Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
Asia-Pacific HIV Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
HIV Drugs Market in Asia-Pacific by Medication Class: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific HIV Drugs Historic Market Scenario in US$ Million by Medication Class: 2009-2017
Asia-Pacific HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025
Australia
HIV Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025
Australian HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017
Australian HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
India
Indian HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018 to 2025
Indian HIV Drugs Historic Market Review by Medication Class in US$ Million: 2009-2017
HIV Drugs Market in India: Percentage Share Breakdown of Sales by Medication Class for 2009, 2019, and 2025
South Korea
HIV Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025
South Korean HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017
HIV Drugs Market Share Distribution in South Korea by Medication Class: 2009 VS 2019 VS 2025
Rest of Asia-Pacific
Rest of Asia-Pacific Market for HIV Drugs: Annual Sales Estimates and Projections in US$ Million by Medication Class for the Period 2018-2025
HIV Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Medication Class for the Period 2009-2017
Rest of Asia-Pacific HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025
Latin America
Latin American HIV Drugs Market Trends by Region/Country in US$ Million: 2018-2025
HIV Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
Latin American HIV Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Latin American HIV Drugs Market Growth Prospects in US$ Million by Medication Class for the Period 2018-2025
HIV Drugs Historic Market Analysis in Latin America in US$ Million by Medication Class: 2009-2017
Latin American HIV Drugs Market by Medication Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Argentina
Argentinean HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018-2025
HIV Drugs Market in Argentina in US$ Million by Medication Class: A Historic Review for the Period 2009-2017
Argentinean HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Brazil
HIV Drugs Market in Brazil by Medication Class: Estimates and Projections in US$ Million for the Period 2018-2025
Brazilian HIV Drugs Historic Market Scenario in US$ Million by Medication Class: 2009-2017
Brazilian HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025
Mexico
HIV Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025
Mexican HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017
Mexican HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Rest of Latin America
Rest of Latin America HIV Drugs Market Estimates and Projections in US$ Million by Medication Class: 2018 to 2025
HIV Drugs Market in Rest of Latin America by Medication Class: A Historic Review in US$ Million for 2009-2017
Rest of Latin America HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Middle East
The Middle East HIV Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
HIV Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017
The Middle East HIV Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
The Middle East HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018 to 2025
The Middle East HIV Drugs Historic Market by Medication Class in US$ Million: 2009-2017
HIV Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Medication Class for 2009, 2019, and 2025
Iran
Iranian Market for HIV Drugs: Annual Sales Estimates and Projections in US$ Million by Medication Class for the Period 2018-2025
HIV Drugs Market in Iran: Historic Sales Analysis in US$ Million by Medication Class for the Period 2009-2017
Iranian HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025
Israel
Israeli HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018-2025
HIV Drugs Market in Israel in US$ Million by Medication Class: A Historic Review for the Period 2009-2017
Israeli HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Saudi Arabia
Saudi Arabian HIV Drugs Market Growth Prospects in US$ Million by Medication Class for the Period 2018-2025
HIV Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Medication Class: 2009-2017
Saudi Arabian HIV Drugs Market by Medication Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Arab Emirates
HIV Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025
United Arab Emirates HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017
HIV Drugs Market Share Distribution in United Arab Emirates by Medication Class: 2009 VS 2019 VS 2025
Rest of Middle East
HIV Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025
Rest of Middle East HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017
Rest of Middle East HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Africa
African HIV Drugs Market Estimates and Projections in US$ Million by Medication Class: 2018 to 2025
HIV Drugs Market in Africa by Medication Class: A Historic Review in US$ Million for 2009-2017
African HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025
Total Companies Profiled: 52

General queries: Info411@StrategyR.com